SYSA1901

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYSA1901, covering 2023-02-09 to 2023-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer [Phase 3]